Cargando…

Results of systemic treatment of cutaneous melanoma in inoperable stage III and IV

AIM OF THE STUDY: The incidence of melanoma is increasing rapidly worldwide. Metastatic melanoma is still an incurable disease, although an era of new drugs is approaching. Current methods to predict outcomes in patients with advanced, metastatic melanoma are limited. A retrospective analysis of a c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cybulska-Stopa, Bożena, Skoczek, Marta, Ziobro, Marek, Świtaj, Tomasz, Falkowski, Sławomir, Morysiński, Tadeusz, Hetnał, Marcin, Cedrych, Ida, Rutkowski, Piotr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2013
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687473/ https://www.ncbi.nlm.nih.gov/pubmed/23788941 http://dx.doi.org/10.5114/wo.2012.32487

Ejemplares similares

Evaluation of vinorelbine-based chemotherapy as the second or further-line treatment in patients with metastatic breast cancer
por: Cybulska-Stopa, Bożena, et al.
Publicado: (2013)

Immune checkpoint inhibitors therapy in older patients (≥ 70 years) with metastatic melanoma: a multicentre study
por: Cybulska-Stopa, Bożena, et al.
Publicado: (2019)

Treatment of Locally Advanced Merkel Cell Carcinoma—A Multi-Center Study
por: Dudzisz-Sledz, Monika, et al.
Publicado: (2022)

Principles of prophylactic and therapeutic management of skin toxicity during treatment with checkpoint inhibitors
por: Kamińska-Winciorek, Grażyna, et al.
Publicado: (2019)

The Long-Term Outcomes of Intensive Combined Therapy of Adult Patients with Localised Synovial Sarcoma
por: Kozak, Katarzyna, et al.
Publicado: (2020)

Long-Term Outcomes of Targeted Therapy after First-Line Immunotherapy in BRAF-Mutated Advanced Cutaneous Melanoma Patients—Real-World Evidence
por: Rogala, Paweł, et al.
Publicado: (2022)

Efficacy and safety of ipilimumab therapy in patients with metastatic melanoma: a retrospective multicenter analysis
por: Wiater, Katarzyna, et al.
Publicado: (2013)

Multimodal Treatment of Advanced Mucosal Melanoma in the Era of Modern Immunotherapy
por: Teterycz, Pawel, et al.
Publicado: (2020)

Molecular alterations in clinical stage III cutaneous melanoma: Correlation with clinicopathological features and patient outcome
por: RUTKOWSKI, PIOTR, et al.
Publicado: (2014)

Survival of patients with stage IIIC and IIID melanomas with nodal metastases in the light of new therapies
por: Ziętek, Marcin, et al.
Publicado: (2022)

Neglected malignant neoplasms with cutaneous involvement
por: Kaminska-Winciorek, Grażyna, et al.
Publicado: (2021)

The Current Treatment Trends and Survival Patterns in Melanoma Patients with Positive Sentinel Lymph Node Biopsy (SLNB): A Multicenter Nationwide Study
por: Ziętek, Marcin, et al.
Publicado: (2023)

Long Term Results and Prognostic Biomarkers for Anti-PD1 Immunotherapy Used after BRAFi/MEKi Combination in Advanced Cutaneous Melanoma Patients
por: Rogala, Paweł, et al.
Publicado: (2022)

Systemic Treatment for Advanced and Metastatic Malignant Peripheral Nerve Sheath Tumors—A Sarcoma Reference Center Experience
por: Sobczuk, Paweł, et al.
Publicado: (2020)

Efficacy and Safety of Hypofractionated Preoperative Radiotherapy for Primary Locally Advanced Soft Tissue Sarcomas of Limbs or Trunk Wall
por: Koseła-Paterczyk, Hanna, et al.
Publicado: (2021)

Real-world treatment practice in patients with advanced melanoma
por: Cybulska-Stopa, Bożena, et al.
Publicado: (2020)

Long-Term Real-World Outcomes and Safety of Vemurafenib and Vemurafenib + Cobimetinib Therapy in Patients with BRAF-Mutated Melanoma
por: Piejko, Karolina, et al.
Publicado: (2023)

The analysis of the long-term outcomes of sorafenib therapy in routine practice in imatinib and sunitinib resistant gastrointestinal stromal tumors (GIST)*
por: Rutkowski, Piotr, et al.
Publicado: (2017)

The Analysis of Trends in Survival for Patients with Melanoma Brain Metastases with Introduction of Novel Therapeutic Options before the Era of Combined Immunotherapy—Multicenter Italian–Polish Report
por: Placzke, Joanna, et al.
Publicado: (2022)

Age as a Prognostic Factor in Patients with Ewing Sarcoma—The Polish Sarcoma Group Experience
por: Jagodzińska-Mucha, Paulina, et al.
Publicado: (2021)

Modern Approach to Melanoma Adjuvant Treatment with Anti-PD1 Immune Check Point Inhibitors or BRAF/MEK Targeted Therapy: Multicenter Real-World Report
por: Placzke, Joanna, et al.
Publicado: (2023)

Immune-Related Pancytopenia Induced by Anti-PD-1 Therapy – Interrupt or Continue Treatment – The Role of Immunohistochemical Examination
por: Cybulska-Stopa, Bożena, et al.
Publicado: (2019)

Efficacy of Neoadjuvant Targeted Therapy for Borderline Resectable III B-D or IV Stage BRAF (V600) Mutation-Positive Melanoma
por: Czarnecka, Anna M., et al.
Publicado: (2021)

Denosumab treatment of inoperable or locally advanced giant cell tumor of bone
por: Borkowska, Aneta, et al.
Publicado: (2016)

Advances in Molecular Characterization and Targeted Therapy in Dermatofibrosarcoma Protuberans
por: Rutkowski, Piotr, et al.
Publicado: (2011)

Systemic treatment in patients with malignant pleural mesothelioma – real life experience
por: Ziółkowska, Barbara, et al.
Publicado: (2022)

Electrochemotherapy Plus IL-2+IL-12 Gene Electrotransfer in Spontaneous Inoperable Stage III–IV Canine Oral Malignant Melanoma
por: Tellado, Matías, et al.
Publicado: (2023)

The Use of ctDNA for BRAF Mutation Testing in Routine Clinical Practice in Patients with Advanced Melanoma
por: Sobczuk, Paweł, et al.
Publicado: (2022)

Characteristics of Giant Nodular Melanomas in Special Locations: a Case Series and Review of the Literature
por: Kamińska-Winciorek, Grażyna, et al.
Publicado: (2022)

Surgery and radiotherapy in the treatment of cutaneous melanoma
por: Testori, A., et al.
Publicado: (2009)

Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall: Results of a Single-Arm Prospective Clinical Trial
por: Koseła-Paterczyk, Hanna, et al.
Publicado: (2020)

High rates of undiagnosed and untreated osteoporosis in postmenopausal women receiving medical services in the area of Upper Silesia
por: Hachuła, Marcin, et al.
Publicado: (2020)

The long-term results and prognostic significance of cutaneous melanoma surgery using sentinel node biopsy with triple technique
por: Rutkowski, Piotr, et al.
Publicado: (2015)

Male breast cancer: a clinicopathological study of an Egyptian population (Alexandria experience)
por: Soliman, Maher, et al.
Publicado: (2016)

Inoperable Cancer
Publicado: (1901)

Gene expression profiling of peripheral blood cells: new insights into Ewing sarcoma biology and clinical applications
por: Przybyl, Joanna, et al.
Publicado: (2014)

Analysis of adverse events of sunitinib in patients treated for advanced renal cell carcinoma
por: Domagała-Haduch, Małgorzata, et al.
Publicado: (2016)

The outcomes of Polish patients with advanced BRAF-positive melanoma treated with vemurafenib in a safety clinical trial
por: Rutkowski, Piotr, et al.
Publicado: (2015)

Cisplatin, gemcitabine, and treosulfan in relapsed stage IV cutaneous malignant melanoma patients
por: Atzpodien, J, et al.
Publicado: (2007)

Analysis of efficacy and safety of vismodegib therapy in patients with advanced basal cell carcinoma – real world multicenter cohort study
por: Słowińska, M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_blomcl8389dudq2usbna5e51a9